EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation






American Journal of Pathology 184(5): 1577-1592

Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation

Lymphatics proliferate, become enlarged, or regress in multiple inflammatory lung diseases in humans. Lymphatic growth and remodeling is known to occur in the mouse trachea in sustained inflammation, but whether intrapulmonary lymphatics exhibit similar plasticity is unknown. We examined the time course, distribution, and dependence on vascular endothelial growth factor receptor (VEGFR)-2/VEGFR-3 signaling of lung lymphatics in sustained inflammation. Lymphatics in mouse lungs were examined under baseline conditions and 3 to 28 days after Mycoplasma pulmonis infection, using prospero heomeobox 1-enhanced green fluorescence protein and VEGFR-3 as markers. Sprouting lymphangiogenesis was evident at 7 days. Lymphatic growth was restricted to regions of bronchus-associated lymphoid tissue (BALT), where VEGF-C-producing cells were scattered in T-cell zones. Expansion of lung lymphatics after infection was reduced 68% by blocking VEGFR-2, 83% by blocking VEGFR-3, and 99% by blocking both receptors. Inhibition of VEGFR-2/VEGFR-3 did not prevent the formation of BALT. Treatment of established infection with oxytetracycline caused BALT, but not the lymphatics, to regress. We conclude that robust lymphangiogenesis occurs in mouse lungs after M. pulmonis infection through a mechanism involving signaling of both VEGFR-2 and VEGFR-3. Expansion of the lymphatic network is restricted to regions of BALT, but lymphatics do not regress when BALT regresses after antibiotic treatment. The lung lymphatic network can thus expand in sustained inflammation, but the expansion is not as reversible as the accompanying inflammation.


Accession: 055116948

PMID: 24631179

DOI: 10.1016/j.ajpath.2014.01.021



Related references

Hwang, J.Young.; Randall, T.D.; Silva-Sanchez, A., 2016: Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung. Following pulmonary inflammation, leukocytes that infiltrate the lung often assemble into structures known as inducible Bronchus-Associated Lymphoid Tissue (iBALT). Like conventional lymphoid organs, areas of iBALT have segregated B and T cell are...

Bánfi, A.; Tiszlavicz, László.; Székely, Eár.; Peták, F.; Tóth-Szüki, Véria.; Baráti, L.; Bari, F.; Novák, Zán., 2009: Development of bronchus-associated lymphoid tissue hyperplasia following lipopolysaccharide-induced lung inflammation in rats. Gram-negative bacterial endotoxin lipopolysaccharide (LPS) administration has been used as an animal model of sepsis-related acute lung injury and adult respiratory distress syndrome (ALI/ARDS). This paper describes the lung histology following lu...

Upadrashta B.S.; Withers J.H.; Croom J.E.; Richerson H.B., 1986: T cell localization in gut associated lymphoid tissue bronchus associated lymphoid tissue and lung parenchyma in rabbit models of hypersensitivity pneumonitis. Federation Proceedings 45(4): 995

Breel, M.; van der Ende, M.B.; Sminia, T.; Kraal, G., 1988: Subpopulations of non-lymphoid cells in bronchus associated lymphoid tissue and lung of the mouse. Advances in Experimental Medicine and Biology 237: 607-613

Gregson, R.L.; Edmondson, N.A.; Plesch, B., 1982: Preferential uptake of soluble antigen by respiratory tract epithelium overlying bronchus-associated lymphoid tissue in the rat. Soluble protein antigen (Horseradish peroxidase - HRP) administered to rats intratracheally is predominantly phagocytosed by alveolar macrophages and Type-II pneumonocytes. A proportion, after localization on the lumenal surface of the bronchiolar...

Gemma, H.; Sato, A., 1989: Effect of glucocorticoid on lung tissue and bronchus-associated lymphoid tissue of experimental granulomatous lung. The effect of glucocorticoid on the immunological response in the delayed type hypersensitivity reaction of granulomatous disorders was investigated in order to elucidate the mechanism of glucocorticoid on the suppressive course of the reaction. E...

Otsuki, Y.; Ito, Y.; Magari, S., 1989: Lymphocyte subpopulations in high endothelial venules and lymphatic capillaries of bronchus-associated lymphoid tissue (BALT) in the rat. The subpopulations of lymphocytes and non-lymphoid cells in high endothelial venules (HEV) and in lymphatic capillaries surrounding lymphoid follicles in bronchus-associated lymphoid tissue (BALT) were examined by electron microscopy after preembe...

Chung, J-Joon.; Kim, M-Jin.; Kie, J-Hae.; Kim, K.Whang., 2005: Mucosa-associated lymphoid tissue lymphoma of the esophagus coexistent with bronchus-associated lymphoid tissue lymphoma of the lung. Non-Hodgkin's lymphoma very rarely involves the esophagus, occurring in less than 1% of patients with gastrointestinal lymphoma. A few cases of mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus have been reported in the Engli...

Koch, J.S.; Whitman, G.J.; Chew, F.S., 1997: Bronchus-associated lymphoid tissue hyperplasia of the lung. Ajr. American Journal of Roentgenology 168(4): 1044-1044

Shenoy, K.V.; Solomides, C.; Cordova, F.; Rogers, T.J.; Ciccolella, D.; Criner, G.J., 2012: Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection. Background. Bronchus-associated lymphoid tissue (BALT) has been associated with lung allograft rejection in rat transplant models. In human transplant recipients, BALT has not been linked to clinically significant rejection. We hypothesize that th...